BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The B and T lymphocyte attenuator (BTLA) is an Ig super family member that binds to the herpes virus entry mediator (HVEM), a TNF receptor super family (TNFRSF) member. Engagement of BTLA by HVEM triggers inhibitory signals, although recent evidence indicates that BTLA also may act as an activating ligand for HVEM. In this study, we reveal a novel role for the BTLA-HVEM pathway in promoting the survival of activated CD8(+) T cells in the response to an oral microbial infection. Our data show that both BTLA- and HVEM-deficient mice infected with Listeria monocytogenes had significantly reduced numbers of primary effector and memory CD8(+) T cells, despite normal proliferation and expansion compared to controls. In addition, blockade of the BTLA-HVEM interaction early in the response led to significantly reduced numbers of antigen-specific CD8(+) T cells. HVEM expression on the CD8(+) T cells as well as BTLA expression on a cell type other than CD8(+) T lymphocytes, was required. Collectively, our data demonstrate that the function of the BTLA-HVEM pathway is not limited to inhibitory signaling in T lymphocytes, and instead, that BTLA can provide crucial, HVEM-dependent signals that promote survival of antigen activated CD8(+) T cell during bacterial infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, BTLA and herpesvirus entry mediator (HVEM) shares ligand on the same T lymphocytes (CD8+), and the same cell interaction happens, which suppresses T cell function [333].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [333]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883 · cited 5×
“Btla [3] and Hvem [9] mice were generously provided by Dr.”
BackgroundInfluentialCo-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1148 · Cited by 863
Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C., Yu, G.-L., Ruben, S., Murphy, M., Eisenberg, R. J., Cohen, G. H., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80455-0 · Cited by 768
Self-citationSignals required for programming effector and memory development by CD8+ T cells
Mescher, M. F., Curtsinger, J. M., Agarwal, P., Casey, K. A., Gerner, M., Hammerbeck, C. D., Popescu, F., & Xiao, Z. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00382.x · Cited by 601
Herpes simplex virus: receptors and ligands for cell entry
Spear, P. G. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00389.x · Cited by 581
Organ-Specific Regulation of the CD8 T Cell Response to Listeria monocytogenes Infection
Pope, C., Kim, S.-K., Marzo, A., Williams, K., Jiang, J., Shen, H., & Lefrançois, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3402 · Cited by 375
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
Cai, G., Anumanthan, A., Brown, J. A., Greenfield, E. A., Zhu, B., & Freeman, G. J. (2008) · Nature Immunology · doi:10.1038/ni1554 · Cited by 345 · cited 1×
“More recently, CD160 was identified as a second Ig-domain containing molecule able to bind HVEM [8].”
BackgroundAranda, R., Sydora, B. C., McAllister, P. L., Binder, S. W., Yang, H. Y., Targan, S. R., & Kronenberg, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3464 · Cited by 312 · cited 1×
“performed as described previously [32].”
Self-citationScheu, S., Alferink, J., Pötzel, T., Barchet, W., Kalinke, U., & Pfeffer, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020215 · Cited by 260 · cited 1×
“Whereas in studies performed in vitro, the costimulatory function of LIGHT was required for optimal CD8 T cell activation, [25,26,27,28,29], LIGHT expression in mice was not required to control Listeria or”
BackgroundGonzalez, L. C., Loyet, K. M., Calemine-Fenaux, J., Chauhan, V., Wranik, B., Ouyang, W., & Eaton, D. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409071102 · Cited by 252 · cited 1×
“Interestingly, recent reports from Ertl and colleagues showed that the viral ligand HSV-1 gD, which competes for HVEM binding with BTLA [21,22], can enhance the adaptive immune response to viral antigens [23,24].”
BackgroundCheung, T. C., Humphreys, I. R., Potter, K. G., Norris, P. S., Shumway, H. M., Tran, B. R., Patterson, G., Jean-Jacques, R., Yoon, M., Spear, P. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506172102 · Cited by 209 · cited 1×
“Interestingly, recent reports from Ertl and colleagues showed that the viral ligand HSV-1 gD, which competes for HVEM binding with BTLA [21,22], can enhance the adaptive immune response to viral antigens [23,24].”
Self-citationHan, P., Goularte, O. D., Rufner, K., Wilkinson, B., & Kaye, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5931 · Cited by 201
The role of herpesvirus entry mediator as a negative regulator of T cell–mediated responses
Wang, Y., Subudhi, S. K., Anders, R. A., Lo, J., Sun, Y., Blink, S., Wang, Y., Wang, J., Liu, X., Mink, K., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522982 · Cited by 197 · cited 3×
“In addition, both HVEM and BTLA-deficient mice have a higher susceptibility to experimental autoimmune encephalomyelitis [3,9], while the loss of BTLA dramatically accelerated partially MHC-mismatched cardiac allograft rejection [10] and prolonged airway inflammation [11].”
BackgroundUnconventional ligand activation of herpesvirus entry mediator signals cell survival
Cheung, T. C., Steinberg, M. W., Oborne, L. M., Macauley, M. G., Fukuyama, S., Sanjo, H., D'Souza, C., Norris, P. S., Pfeffer, K., Murphy, K. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902115106 · Cited by 192 · cited 6×
“It can function as an Ig super family ligand for HVEM that triggers activation of the NF-kB pathway [16].”
BackgroundResultInfluentialSelf-citationCheung, T. C., Oborne, L. M., Steinberg, M. W., Macauley, M. G., Fukuyama, S., Sanjo, H., D'Souza, C., Norris, P. S., Pfeffer, K., Murphy, K. M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902490 · Cited by 153 · cited 11×
“In the cis configuration, however, BTLA-HVEM binding antagonized NF-kB activation, suggesting that in cis these molecules may have a largely inhibitory function [17].”
BackgroundInfluentialSelf-citationB and T lymphocyte attenuator regulates CD8+ T cell–intrinsic homeostasis and memory cell generation
Krieg, C., Boyman, O., Fu, Y., & Kaye, J. (2007) · Nature Immunology · doi:10.1038/ni1418 · Cited by 148 · cited 1×
“A role for the BTLA-HVEM interaction in decreasing the memory CD8 T cell pool, for example during homeostatic expansion, has been reported [20].”
BackgroundA crucial role for HVEM and BTLA in preventing intestinal inflammation
Steinberg, M. W., Turovskaya, O., Shaikh, R. B., Kim, G., McCole, D. F., Pfeffer, K., Murphy, K. M., Ware, C. F., & Kronenberg, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071160 · Cited by 137 · cited 3×
“to prevent severe disease and destructive inflammatory immune responses in a colitis model induced by the transfer of naı̈ve CD4 T cells into Rag mice [13].”
BackgroundResultSelf-citationTao, R., Wang, L., Han, R., Wang, T., Ye, Q., Honjo, T., Murphy, T. L., Murphy, K. M., & Hancock, W. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5774 · Cited by 120 · cited 2×
“To confirm this by pharmacologic inhibition, and to rule out a developmental defect due to germ line gene deletion, we performed experiments using an anti-BTLA (clone 6A6) monoclonal antibody (mAb) that competitively inhibits HVEM-BTLA binding interactions [10,14,18].”
BackgroundMethodTamada, K., Ni, J., Zhu, G., Fiscella, M., Teng, B., van Deursen, J. M. A., & Chen, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4832 · Cited by 93 · cited 1×
“Whereas in studies performed in vitro, the costimulatory function of LIGHT was required for optimal CD8 T cell activation, [25,26,27,28,29], LIGHT expression in mice was not required to control Listeria or”
BackgroundDeppong, C., Juehne, T. I., Hurchla, M., Friend, L. D., Shah, D. D., Rose, C. M., Bricker, T. L., Shornick, L. P., Crouch, E. C., Murphy, T. L., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3909 · Cited by 89 · cited 1×
“In addition, both HVEM and BTLA-deficient mice have a higher susceptibility to experimental autoimmune encephalomyelitis [3,9], while the loss of BTLA dramatically accelerated partially MHC-mismatched cardiac allograft rejection [10] and prolonged airway inflammation [11].”
BackgroundTargeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses
Lasaro, M. O., Tatsis, N., Hensley, S. E., Whitbeck, J. C., Lin, S., Rux, J. J., Wherry, E. J., Cohen, G. H., Eisenberg, R. J., & Ertl, H. C. J. (2008) · Nature Medicine · doi:10.1038/nm1704 · Cited by 83 · cited 1×
“Interestingly, recent reports from Ertl and colleagues showed that the viral ligand HSV-1 gD, which competes for HVEM binding with BTLA [21,22], can enhance the adaptive immune response to viral antigens [23,24].”
BackgroundHurchla, M. A., Sedy, J. R., & Murphy, K. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6073 · Cited by 81 · cited 5×
“A role for BTLA in promoting T cell survival has been reported in several experiments [13,14,15,16], although the opposite was found in one study [19].”
BackgroundMethodResultInfluentialHerpesvirus entry mediator (TNFRSF14) regulates the persistence of T helper memory cell populations
Soroosh, P., Doherty, T. A., So, T., Mehta, A. K., Khorram, N., Norris, P. S., Scheu, S., Pfeffer, K., Ware, C. F., & Croft, M. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101562 · Cited by 76
Self-citationCross-regulation between herpesviruses and the TNF superfamily members
Šedý, J. R., Spear, P. G., & Ware, C. F. (2008) · Nature Reviews Immunology · doi:10.1038/nri2434 · Cited by 74 · cited 1×
“Furthermore, HVEM can function as the receptor for the herpes simplex virus glycoprotein D (HSV-1 gD), which allows HSV-1 and 2 entry into cells [6,7].”
BackgroundSelf-citationDichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway
Sakoda, Y., Park, J.-J., Zhao, Y., Kuramasu, A., Geng, D., Liu, Y., Davila, E., & Tamada, K. (2011) · Blood · doi:10.1182/blood-2010-08-301325 · Cited by 54 · cited 6×
“In this experimental setup, the critical survival signal for HVEMexpressing T cells was provided by BTLA expressed on T lymphocytes, presumably during T cell -T cell encounters [15].”
BackgroundMethodResultInfluentialB and T Lymphocyte Attenuator Tempers Early Infection Immunity
Sun, Y., Brown, N. K., Ruddy, M. J., Miller, M. L., Lee, Y., Wang, Y., Murphy, K. M., Pfeffer, K., Chen, L., Kaye, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801866 · Cited by 51 · cited 1×
“To confirm this by pharmacologic inhibition, and to rule out a developmental defect due to germ line gene deletion, we performed experiments using an anti-BTLA (clone 6A6) monoclonal antibody (mAb) that competitively inhibits HVEM-BTLA binding interactions [10,14,18].”
MethodMiller, M. L., Sun, Y., & Fu, Y.-X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900690 · Cited by 46 · cited 1×
“Similarly, an inhibitory role for BTLA and HVEM has been reported in the Con-A induced hepatitis model [12], and we found previously that the HVEM-BTLA interaction is also critical”
BackgroundLIGHT‐deficiency impairs CD8+ T cell expansion, but not effector function
Liu, J., Schmidt, C. S., Zhao, F., Okragly, A. J., Glasebrook, A. L., Fox, N. W., Galbreath, E. J., Zhang, Q., Song, H. Y., Na, S., et al. (2003) · International Immunology · doi:10.1093/intimm/dxg082 · Cited by 41 · cited 1×
“Whereas in studies performed in vitro, the costimulatory function of LIGHT was required for optimal CD8 T cell activation, [25,26,27,28,29], LIGHT expression in mice was not required to control Listeria or”
BackgroundB and T Lymphocyte Attenuator Regulates T Cell Survival in the Lung
Deppong, C., Degnan, J. M., Murphy, T. L., Murphy, K. M., & Green, J. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2973 · Cited by 36 · cited 1×
“A role for BTLA in promoting T cell survival has been reported in several experiments [13,14,15,16], although the opposite was found in one study [19].”
ResultLIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice
Sedgmen, B. J., Dawicki, W., Gommerman, J. L., Pfeffer, K., & Watts, T. H. (2006) · International Immunology · doi:10.1093/intimm/dxl016 · Cited by 30
DiMenna, L. J., Latimer, B. P., Parzych, E. M., Haut, L. H., Töpfer, K., Abdulla, S., Yu, H. B., Manson, B., Giles‐Davis, W., Zhou, D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903808 · Cited by 29 · cited 1×
“Interestingly, recent reports from Ertl and colleagues showed that the viral ligand HSV-1 gD, which competes for HVEM binding with BTLA [21,22], can enhance the adaptive immune response to viral antigens [23,24].”
BackgroundLIGHT contributes to early but not late control of Mycobacterium tuberculosis infection
Musicki, K., Briscoe, H., Britton, W. J., & Saunders, B. M. (2010) · International Immunology · doi:10.1093/intimm/dxq013 · Cited by 12 · cited 1×
“Whereas in studies performed in vitro, the costimulatory function of LIGHT was required for optimal CD8 T cell activation, [25,26,27,28,29], LIGHT expression in mice was not required to control Listeria or”
Background
Cited by
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses
Ward-Kavanagh, L. K., Lin, W. W., Šedý, J. R., & Ware, C. F. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.019 · Cited by 463
Self-citationTumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Kumar, P., Bhattacharya, P., & Prabhakar, B. S. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.007 · Cited by 216
“BTLA is expressed on T-cells and APCs, whereas its ligand/counter-receptor HVEM is expressed on resting and activated T-cells[66].”
BackgroundThe function and dysfunction of memory CD 8+ T cells in tumor immunity
Reading, J. L., Gálvez‐Cancino, F., Swanton, C., Lladser, A., Peggs, K. S., & Quezada, S. A. (2018) · Immunological Reviews · doi:10.1111/imr.12657 · Cited by 180
Natural and Induced Tolerogenic Dendritic Cells
Iberg, C. A., & Hawiger, D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901121 · Cited by 159
Metadata
- Authors
- Steinberg, M. W., Huang, Y., Wang-Zhu, Y., Ware, C. F., Cheroutre, H., & Kronenberg, M.
- Affiliations
- La Jolla Institute for Immunology (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Kronenberg, Mitchell
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-30
- Volume
- 8
- Issue
- 10
- Pages
- e77992
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3813523
- OpenAlex
- W2019871490
- Cited by
- 55
- References
- 32
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 2 · 2016: 6 · 2015: 5 · 2014: 3
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (5r01ai050265-13, PO1 DK46763, DK46763)
- National Institute of Allergy and Infectious Diseases (R01AI048073, R01AI061516, AI050265, R01-AI050265, R01AI067890, AI048073, R37AI033068, AI064584, R56AI050265, R01AI064584, AI067890)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763)
- National Center for Research Resources (S10RR027366)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- BTLA, HVEM, CD8+ T cells, T cell survival, memory T cells, Listeria monocytogenes, oral bacterial infections, T cell activation, inhibitory signaling, TNF receptor superfamily
- MeSH terms
- Animals, Cells, Cultured, Flow Cytometry, Fluorescent Antibody Technique, Listeria monocytogenes, Mice, Inbred C57BL, Protein Binding, Receptors, Immunologic, CD8-Positive T-Lymphocytes, Mice, Receptors, Tumor Necrosis Factor, Member 14
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.